fbpx

Day

December 11, 2015
Veloxis Pharmaceuticals A/S (NASDAQ: VELO) announced today that Dr. William J. Polvino steps down as President and CEO after more than six years in the role.
93% of patients had full or partial cyst resolution at 12 months. No post-operative infections reported during follow-up period. No fractures reported during the follow-up period

News

Vægt
Danish researchers: Obesity is located in the brain
24. September 2020
DNA analysis of 442 Viking skeletons rewrites the story of Viking culture
16. September 2020
Hope that a brain injection could cure type 2 diabetes
7. September 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge